NCT05546385

PArtial REbreathing for Migraine With Aura 1

A Prospective, Multi-centre, Randomized, Double-blind, Sham-controlled, Parallel-group, Group-sequential Study to Investigate Safety and Effectiveness of the Rehaler Partial Rebreathing Device, in Adults Suffering From Migraine With Aura

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 142 (actual)
• Sponsor: Rehaler · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

A prospective, multi-centre, randomized, double-blind, sham-controlled, parallel-group, group-sequential study to investigate safety and effectiveness of the Rehaler partial rebreathing device, in adults suffering from migraine with aura

Conditions

• Migraine With Aura

Interventions

Type	Name	Description
DEVICE	Partial Rebreathing Device	Partial Rebreathing Device
DEVICE	Sham breathing device	Sham breathing device

Timeline

• Start date: 2023-08-08
• Primary completion: 2024-10-30
• Completion: 2024-10-30
• First posted: 2022-09-19
• Last updated: 2025-03-25
• Results posted: 2025-03-25

Locations

15 sites across 2 countries: United States, Germany